NEW YORK (Reuters Health) – A recent prospective study disproves earlier observations that non-steroidal anti-inflammatory drugs (NSAIDS) prevent Alzheimer dementia (AD). At best, NSAIDS may delay its onset,…
NEW YORK (Reuters Health) – Vilazodone, the first of a new class of antidepressants known as indolalkylamines, has been shown in a phase III trial to be effective…
NEW YORK (Reuters Health) – Elderly patients with Alzheimer’s disease treated with second-generation antipsychotics should be monitored closely for weight gain and dyslipidemia, according to an analysis of…
NEW YORK (Reuters Health) – Three milligrams of melatonin at bedtime can effectively treat sleep problems in children with autistic spectrum disorder or fragile X syndrome or both,…
NEW YORK (Reuters Health) – Certain women may be at risk of developing systemic lupus erythematosus (SLE) when they start taking combined oral contraceptives, according to investigators at…
NEW YORK (Reuters Health) – Use of valproate during pregnancy compared with other antiepileptic drugs is associated with reduced cognitive function in offspring at 3 years of age,…
NEW YORK (Reuters Health) – Desvenlafaxine, a serotonin-norepinephrine reuptake inhibitor, is a safe and effective treatment for hot flushes in postmenopausal women, according to a report in the…
NEW YORK (Reuters Health) – Bezafibrate, a pan-PPAR agonist used widely for treating dyslipidemia in the UK, appears to prevent or delay the development of type 2 diabetes,…
NEW YORK (Reuters Health) – The results of a new study suggest that tuberculosis may be cured faster by adding moxifloxacin to a standard TB treatment protocol than…
NEW YORK (Reuters Health) – The results of a placebo-controlled trial suggest that controlled-release oxycodone is an effective treatment for acute pain due to herpes zoster, whereas gabapentin…